title: The increasing prevalence of listeriosis--what are we missing?
authors.affiliation: Department of Microbiology, John Radcliffe Hospital, Oxford OX3 9DU, UK. elham.khatamzas@imm.ox.ac.uk
authors.forename: E
authors.initials: E
authors.lastname: Khatamzas
authors.forename: H
authors.initials: H
authors.lastname: Hughes
authors.forename: K A
authors.initials: KA
authors.lastname: Grant
authors.forename: J
authors.initials: J
authors.lastname: McLauchlin
authors.forename: I C J W
authors.initials: IC
authors.lastname: Bowler
mesh_terms: D000368:Aged; D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D004032:Diet; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008089:Listeria monocytogenes / Q000302:isolation & purification; D008088:Listeriosis / Q000453:epidemiology / Q000209:etiology*; D008297:Male; D015995:Prevalence; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000658:Amoxicillin